Skip to main content
Log in

Les nouvelles technologies en radiothérapie : RCMI, stéréotaxie, hadronthérapie… quel intérêt médical et quelles conséquences psychologiques pour les patients ?

New technologies in radiotherapy: IMRT, stereotactic body radiation therapy, hadrontherapy… What medical interest and what psychological consequences?

  • Article Original / Original Article
  • Published:
Psycho-Oncologie

Résumé

La radiothérapie vit une véritable révolution technologique depuis les années 1990, grâce notamment aux progrès de l’imagerie, à l’optimisation de la distribution de la dose délivrée au volume à irradier, par l’utilisation de la radiothérapie conformationnelle par modulation d’intensité (RCMI) ou par la diffusion de la radiothérapie stéréotaxique (RST), avec pour objectif l’augmentation du taux de guérison et l’amélioration de la tolérance des traitements. Après une présentation rapide des nouvelles technologies en radiothérapie, nous nous intéresserons à leur impact psychologique sur les patients mais également sur les soignants.

Abstract

Radiotherapy oncology is a field that has rapidly advanced over the last three decades, thanks to the breakthrough of the diagnostic imaging, to the development of new radiotherapy techniques such as intensity-modulated radiation therapy (IMRT) and the stereotactic body radiation therapy (SBRT) with an enhanced ability to optimize the dose distribution. These technological advances aimed to increase survival rates and to improve tolerance of treatments. After a brief presentation of new technologies in radiotherapy, we focus on their psychological impact not only on patients but also on caregivers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. http://www.has-sante.fr [Internet]. Available from: http://www. has-sante.fr/portail/upload/docs/application/pdf/2015-03/rapport_ rcmi_col_uterus_vd_2015-03-09_10-26-53_423.pdf

  2. Marta GN, Silva V, de Andrade-Carvalho H, et al (2014) Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol J Eur Soc Ther Radiol Oncol 110:9–15

    Article  Google Scholar 

  3. Barillot I, Tavernier E, Peignaux K, et al (2014) Impact of postoperative intensity modulated radiotherapy on acute gastrointestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 111:138–43

    Article  Google Scholar 

  4. Intérêt de la radiothérapie extracrânienne en conditions stéréotaxiques. Available from: http://www.has-sante.fr/portail/upload/ docs/application/pdf/synthese_stereo_cyber.pdf

  5. Bibault JE, Prevost B, Dansin E, et al (2010) Stereotactic radiotherapy for lung cancer: non-invasive real-time tumor tracking. Cancer Radiother J Soc Fr Radiother Oncol 14:690–7

    Google Scholar 

  6. Bibault JE, Prevost B, Dansin E, et al (2012) Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol Lond Engl 7:102

    Article  Google Scholar 

  7. Lagrange JL, de Crevoisier R (2010) Image guided radiation therapy (IGRT). Bull Cancer (Paris) 97:857–65

    Google Scholar 

  8. Louvel G, Cazoulat G, Chajon E, et al (2012) Radiothérapie guidée par l’image et adaptative. Cancer/Radiothérapie 16:423–9

    Article  Google Scholar 

  9. Lim G, Bezjak A, Higgins J, et al (2011) Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 6:531–6

    Google Scholar 

  10. Ramsey CR, Langen KM, Kupelian PA, et al (2006) A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol 64:1237–44

    Article  Google Scholar 

  11. Wan-Leung S, Lee TF, Chien CY, et al (2011) Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer 11:128

    Article  PubMed  PubMed Central  Google Scholar 

  12. Saarilahti K, Kouri M, Collan J, et al (2005) Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol J Eur Soc Ther Radiol Oncol 74:251–8

    Article  Google Scholar 

  13. Kwong DLW, Pow EHN, Sham JST, et al (2004) Intensitymodulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101:1584–93

    Article  PubMed  Google Scholar 

  14. Rathod S, Gupta T, Ghosh-Laskar S, et al (2013) Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol 49:634–42

    Article  PubMed  Google Scholar 

  15. Versmessen H, Vinh-Hung V, Van Parijs H, et al (2012) Healthrelated quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC Cancer 12:495

    Article  PubMed  PubMed Central  Google Scholar 

  16. Van der Voort van Zyp NC, Prévost JB, van der Holt B, et al (2010) Quality of life after stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77:31–7

    Article  PubMed  Google Scholar 

  17. Sun V, Kim JY, Williams AC, et al (2014) Quality of life and symptoms following stereotactic body radiotherapy in early-stage lung cancer patients. J Community Support Oncol 12(11):407–14

    Article  PubMed  PubMed Central  Google Scholar 

  18. Videtic GMM, Reddy CA, Sorenson L (2013) A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21:211–8

    Google Scholar 

  19. Widder J, Postmus D, Ubbels JF, et al (2011) Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 81: e291–e7

    Article  PubMed  Google Scholar 

  20. Fang P, Tan KS, Grover S, et al (2015) Psychosocial encounters correlates with higher patient-reported functional quality of life in gynecological cancer patients receiving radiotherapy. Radiat Oncol Lond Engl 10:34

    Article  Google Scholar 

  21. Livre blanc de la radiothérapie en France [Internet]. Available from: http://www.sfro.org/client/gfx/utilisateur/File/Livre_blanc_SFRO_ 2013(1).pdf

  22. Bonnet V, Couvreur C, Demachy P, et al (2000) Évaluation des besoins en information des patients suivis en radiothérapie: étude effectuée sur la base du livret de la radiothérapie. Cancer/Radiothérapie 4:294–307

    Article  Google Scholar 

  23. Lartigau EF, Tresch E, Thariat J, et al (2013) Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 109:281–5

    Article  Google Scholar 

  24. Pan H, Simpson DR, Mell LK, et al (2011) A survey of stereotactic body radiation therapy use in the United States. Cancer 117:4566–72

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lopez-Guerra JL, Isa N, Kim MM, et al (2012) New perspectives in radiation oncology: young radiation oncologist point of view and challenges. Rep Pract Oncol Radiother 17:251–4

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to M. Reich or E. Lartigau.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jouin, A., Mirabel, X., Rault, E. et al. Les nouvelles technologies en radiothérapie : RCMI, stéréotaxie, hadronthérapie… quel intérêt médical et quelles conséquences psychologiques pour les patients ?. Psycho Oncologie 9, 240–247 (2015). https://doi.org/10.1007/s11839-015-0548-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11839-015-0548-9

Mots clés

Keywords

Navigation